What companies are SLS's competitors?

SELLAS Life Sciences Group, Inc. (SLS)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.

How does SLS compare to its peers?

The peer comparison table on this page shows SELLAS Life Sciences Group, Inc. (SLS) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.

What sector does SLS operate in?

SELLAS Life Sciences Group, Inc. (SLS) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification: companies with similar revenue mix, cost structure, and customer demand drivers.

SLS

SELLAS Life Sciences Group, Inc.

NASDAQ·Biotechnology · Healthcare

$11.34$0.20−1.73%

After hours·$11.33−0.09%

Market cap$2.29B·Market closed·Oct 26 4:00 PM EDT

Frequently Asked Questions About SLS

What companies are SLS's competitors?: SELLAS Life Sciences Group, Inc. (SLS)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does SLS compare to its peers?: The peer comparison table on this page shows SELLAS Life Sciences Group, Inc. (SLS) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does SLS operate in?: SELLAS Life Sciences Group, Inc. (SLS) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification: companies with similar revenue mix, cost structure, and customer demand drivers.

SLS

SELLAS Life Sciences Group, Inc.

NASDAQ·Biotechnology · Healthcare

$11.34$0.20−1.73%

After hours·$11.33−0.09%

Market cap$2.29B·Market closed·Oct 26 4:00 PM EDT

Peers

Sort:


INCYINCYIncyte Corporation	Incyte Corporation	$113.31	$23.0B
IDYAIDYAIDEAYA Biosciences, Inc.	IDEAYA Biosciences, Inc.	$32.88	$3.2B
NRIXNRIXNurix Therapeutics, Inc.	Nurix Therapeutics, Inc.	$25.55	$2.8B
IMNMIMNMImmunome, Inc.	Immunome, Inc.	$17.89	$2.1B
AAPGAAPGAscentage Pharma Group International	Ascentage Pharma Group International	$15.45	$1.4B
AVBPAVBPArriVent BioPharma, Inc.	ArriVent BioPharma, Inc.	$15.36	$757.4M
CBIOCBIOCrescent Biopharma, Inc.	Crescent Biopharma, Inc.	$12.76	$474.0M
CCCCCCCCC4 Therapeutics, Inc.	C4 Therapeutics, Inc.	$2.98	$366.6M
PRLDPRLDPrelude Therapeutics Incorporated	Prelude Therapeutics Incorporated	$3.70	$214.2M
MGNXMGNXMacroGenics, Inc.	MacroGenics, Inc.	$2.19	$139.5M

Frequently Asked Questions About SLS

What companies are SLS's competitors?: SELLAS Life Sciences Group, Inc. (SLS)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does SLS compare to its peers?: The peer comparison table on this page shows SELLAS Life Sciences Group, Inc. (SLS) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does SLS operate in?: SELLAS Life Sciences Group, Inc. (SLS) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification: companies with similar revenue mix, cost structure, and customer demand drivers.